There is a newer version of the Kansas Statutes
2009 Kansas Code
Chapter 65 PUBLIC HEALTH
Article 6b AMYGDALIN (LAETRILE)
- 65-6b01. Amygdalin (laetrile); definitions.
- 65-6b02. Same; use in treatment by physician, limitations on interference with.
- 65-6b03. Same; when prescribed or administered.
- 65-6b04. Same; act not endorsement; certain treatment by physician not prohibited.
- 65-6b05. Same; written informed request.
- 65-6b06. Amygdalin (laetrile); registration to manufacture; duties of secretary of health and environment; fees.
- 65-6b07. Same; permit to distribute at wholesale; duties of secretary of health and environment; fees; hearing.
- 65-6b08. Same; penalty for violations of act.
- 65-6b09. Same; permit to sell, offer for sale or distribute to public; duties of secretary of health and environment; fees; hearing.
- 65-6b10. Same; amygdalin (laetrile) enforcement fee fund.
- 65-6b11. Same; records required.
- 65-6b12. Same; act not applicable to certain persons.
Disclaimer: These codes may not be the most recent version. Kansas may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.